Pravastatin Sodium
NDC Package 51655-343-52
Package Information
Pravastatin Sodium is tablets are indicated:To reduce the risk of myocardial infarction, myocardial revascularization procedures, and cardiovascular mortality in adults with elevated low-density lipoprotein cholesterol (LDL-C) without clinically evident coronary heart disease (CHD).To reduce the risk of coronary death, myocardial infarction, myocardial revascularization procedures, stroke or transient ischemic attack, and slow the progression of coronary atherosclerosis in adults with clinically evident CHD.As an adjunct to diet to reduce LDL-C in adults with primary hyperlipidemia.As an adjunct to diet to reduce LDL-C in pediatric patients ages 8 years and older with heterozygous familial hypercholesterolemia (HeFH).As an adjunct to diet for the treatment of adults with: Primary dysbetalipoproteinemia.Hypertriglyceridemia. Marketed by Northwind Health Company, Llc, this product is identified by NDC 51655-343 and is authorized under FDA application ANDA076056.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51655 - Northwind Health Company, Llc
- 51655-343 - Pravastatin Sodium
- 51655-343-52 - 30 TABLET in 1 BOTTLE, PLASTIC
- 51655-343 - Pravastatin Sodium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51655-343-52 identifies a specific commercial package of 30 tablet in 1 bottle, plastic of Pravastatin Sodium, labeled by Northwind Health Company, Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Northwind Health Company, Llc on February 28, 2023. The current certification is valid through September 30, 2026.
How is this Northwind Health Company, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51655034352. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.